Market Analysis of Genome Editing and Gene Therapy

The global genome editing market is expected to reach $3,514.08 Million by 2020 from $1,845.25 Million in 2014, at a CAGR of 13.75% between 2014 and 2020. Factors such as rapid increase in the number of pharmaceutical and biotechnology industries, strong trend of R&D in life science research, increasing government funding for genomics, technological advancements, increased demand for synthetic genes, and the overall rise in the production of genetically modified crops are driving the growth of the genome editing market. On the other hand, stringent regulatory policies and ethical issues are major factors restraining the growth of this market.